Table 1.
Energetic contribution to PyDock score.
Complex | Electrostatic energy (kcal/mol) | Desolvation energy (kcal/mol) | VdW (kcal/mol) | RMSD (nm) |
---|---|---|---|---|
Ranibizumab/VEGFA | −7 | −24 | −76 | 0.05 vs. 1CZ8 |
Fab-bevacizumab/VEGFA | −8 | −20 | −62 | 0.05 vs. 1BJ1 |
*VEGFR1d2_R2d3/VEGFA | −22 | −9 | 19 | 0.30 vs. 2X1W 0.20 vs. 3V2A |
**VEGFR1d2_R2d3/VEGFA | −11 | −12 | 34 | 0.40 vs. 2X1W 0.50 vs. 3V2A |
VdW (Van der Waals interaction energy), RMSD (root-mean-square deviation).
Aflibercept binding domain optimized with MD.
Aflibercept binding domain without structural optimization.